ArticleJournal of translational medicine2013

Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients.

Branka Petricevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.